Fundraising Fox

Remix Therapeutics

Watertown, US · Founded 2019 · 5 known investors

remixtx.com ↗

Remix Therapeutics develops RNA reprogramming technology to treat various diseases and disorders. The company applies precision medicine approaches across oncology and other therapeutic areas.

AI & Machine LearningBiotechin /remix-therapeutics@RemixThera

Founders & leadership

PS
Peter Smith, PhDCo-Founder, President and Chief Executive Officer
PS
Peter SmithCo-Founder, President and Chief Executive Officer
RG
Robert GagnonExecutive Officer
MP
Matthew PattersonDirector
KB
Kevin BittermanDirector
JG
Jeff GoaterDirector
MR
Michael RomeDirector
SB
Scott BillerDirector
HW
Heather WassermanExecutive Officer

Investors · 5

Atlas Venture✓ verifiedCambridge · $500K – $1M
Foresite Capital✓ verifiedLarkspur
The Column Group✓ verifiedSan Francisco · $30M
ARCH Venture PartnersChicago · $50K – $250M
Decheng CapitalreportedMenlo Park

Reported raises · per SEC filings

Form D private placements
▶$13.7MraisedJan 2024 · 21 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Peter SmithExecutive Officer, Director
  • Robert GagnonExecutive Officer
  • Matthew PattersonDirector
  • Kevin BittermanDirector
  • Jeff GoaterDirector
  • Michael RomeDirector
  • Scott BillerDirector
  • Heather WassermanExecutive Officer
Offering amount
$90M
Amount sold
$13.7M
First sale
Dec 2023
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news